Apr 22 |
Coya Therapeutics to Participate in the Mizuho Neuroscience Summit
|
Apr 18 |
Coya Therapeutics to Participate in the 3rd Annual ALS Drug Development Summit
|
Apr 8 |
Coya Therapeutics Scientific Advisory Board Chairman Dr. Stanley Appel to Present Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium
|
Mar 27 |
We're Not Very Worried About Coya Therapeutics' (NASDAQ:COYA) Cash Burn Rate
|
Mar 21 |
Coya Therapeutics Inc (COYA) Reports Fiscal 2023 Financial Results and Corporate Updates
|
Mar 19 |
Coya Therapeutics GAAP EPS of -$0.79
|
Mar 19 |
Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2023 Financial Results
|
Mar 12 |
Coya Therapeutics to Participate in BTIG Fireside Discussion
|
Mar 12 |
Coya Therapeutics Presents ALS Biomarker Data at Society of Neuroimmune Pharmacology Conference
|
Mar 6 |
Coya Therapeutics Presents Biomarker Data on Neuroinflammatory Pathways in Frontotemporal Dementia (FTD) at the AD/PD 2024 Conference
|